Watson Pharmaceuticals, Inc. v. Schwetz
Watson Pharmaceuticals, Inc. v. Schwetz
38 F. App'x 578
Watson Pharmaceuticals, Inc. v. Schwetz
Opinion of the Court
ON MOTION
ORDER
Bristol-Myers Squibb Co., Watson Pharmaceuticals, Inc. and Danbury Phar-macal, Inc. move jointly to voluntarily dismiss with prejudice. The Acting Principal Deputy Commissioner consents.
Upon consideration thereof,
IT IS ORDERED THAT:
(1) The unopposed motion to dismiss is granted.
(2) The motion to transfer is moot.
(3) All sides shall bear their own costs.
Case-law data current through December 31, 2025. Source: CourtListener bulk data.